Faculty

Institution

Unit

Venue

Anil Sood

The University of Texas MD Anderson Cancer Center

Affiliations

Center For Rna Interference And Non-Coding Rna

Department Of Gynecologic Oncology And Reproductive Medicine

Department Of Gynecologic Research

The University of Texas MD Anderson Cancer Center

Anil Sood is a Senior Professor at The University of Texas MD Anderson Cancer Center, specializing in gynecologic oncology and cancer biology. His research focuses on ovarian cancer tumor biology, particularly platelet-mediated immune suppression, VISTA expression in the tumor microenvironment, and homologous recombination deficiency in frontline therapy. He has published recent findings on PPP2R1A mutations and improved survival after cancer immunotherapy (Nature, 2025) and combination therapy with copanlisib and niraparib in recurrent ovarian and endometrial cancers (Clinical Cancer Research, 2026). His awards include grants for spatial transcriptomics in immune suppression and non-coding RNA cancer therapeutics.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Anil Sood

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

oncology ovarian cancer gynecologic oncology cancer research gynecology cancer biology tumor biology cancer treatment gynecologic cancers pharmacology molecular biology oncogenes medicinal research cell biology cancer cells cancer care molecular cancer tumor targeting therapeutic targets cancer discovery cancer management cancer genetics vascular biology cancer genomics anti-cancer agents tumor microenvironment cancer growth surgical oncology tumor suppressors pharmacotherapy carcinogenesis cellular therapy enzyme inhibition novel therapies angiogenesis cancer imaging obstetrics and gynaecology ovarian carcinoma cell regulation drug targeting therapeutic efficacy endocrine-related cancers endocrine oncology nanoparticle research rna biology cancer risk blood platelet advanced ovarian cancer molecular cell biology non-coding rna epithelial ovarian cancer microrna detection therapeutic nanomaterials tumor growth ovarian cancer cells signaling pathways neoadjuvant chemotherapy malignant disease cancer prevention long non-coding rna breast oncology tumoral pathology hemostasis nano-drug delivery brain-immune interaction endometrial cancer cancer immunosurveillance ovarian cancer patients cancer progression therapeutic targeting triple-negative breast cancer platinum resistance epithelial ovarian carcinoma clinical outcomes poor prognosis focal adhesion kinase

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract A045: Overcoming Platelet-Mediated Immune Suppression in Ovarian Cancer. Cancer Immunology Research (2026)

immunologyabstract a045blood plateletgynecologic oncologycancer immunotherapycellular therapygynecologic cancersthrombopoiesisgynecologyovarian cancerimmunotherapy

Combination Therapy With Copanlisib and Niraparib in Patients With Recurrent Endometrial and Ovarian Cancer (Copanira): Efficacy, Toxicity, and Translational Insights. Clinical Cancer Research (2026)

medicinepharmacologycancer managementgynecologic oncologypharmacotherapytherapeutic targetsgynecologic cancersoncologytranslational insightsclinical endpointcancer treatmentcombination therapygynecologyovarian cancer

Correlation of Brca and Homologous Recombination Deficiency Status With Clinical and Survival Outcomes in Patients With Advanced-Stage Ovarian Cancer Undergoing Frontline Therapy. International Journal of Gynecological Cancer (2026)

cancer geneticscancer careradiation oncologygynecologic oncologysurvival outcomesgynecologic cancersoncologyfrontline therapycancer treatmentgynecologyovarian canceradvanced-stage ovarian cancer

Platelets Induce Vista Expression and Modulate the Ovarian Tumor Microenvironment. Platelets (2026)

blood platelethematologythrombosistumor microenvironmentovarian cancerhemostasiscell biology

Rethinking Depression Diagnosis in Ovarian Cancer: The Role of Somatic Symptoms. Cancer (2026)

cancer caremood symptomsymptom managementpsychopathologygynecologic oncologydepressionpsychiatryoncologygynecologyovarian cancer

Abstract 6520: Intratumoral Microbiome Profiling Using High-Depth Whole-Genome Sequencing Highlighted Cutibacterium Acnes in Chemoresistance in Ovarian Cancer. Cancer Research (2025)

microbiomeovarian cancerhigh throughput sequencingsystems biologymetagenomicsgynecologic oncologyclinical microbiologyenvironmental microbiologymicrobial geneticshigh-depth whole-genome sequencingmolecular diagnosticsdysbiosisbacteriaabstract 6520microbiology

Abstract 6795: Cystine Deprivation Overcomes Protective Effects of Hypoxia on Ferroptosis in High-Grade Serous Ovarian Cancer. Cancer Research (2025)

oxidative stressredox signalingfree radical biologyredox biologygynecologic oncologyreactive oxygen speciesoncologyhypoxia (medicine)gynecologyovarian cancer

Abstract 7153: Subclonal Mutation Load Predicts Survival and Response to Immunotherapy in Cancers With Low to Moderate Tmb. Cancer Research (2025)

immunologyabstract 7153cancer geneticsimmune checkpoint inhibitorssubclonal mutation loadcancer immunotherapyoncologyoncogenescancer cellspathologyimmunotherapy

Abstract P2-06-04: Potential Impact of the Cancer-Associated Fibroblast Secretome in the Tumor Microenvironment. Clinical Cancer Research (2025)

potential impactcancer-associated fibroblast secretomecancer researchmolecular cancercancer cellstumor microenvironmentcancer biologypathologytumor biologybiological microenvironmentscell biology

Antibody-Targeted, Liposomes Encapsulated Indocyanine Green Dye J-Aggregates as Contrast Agents for Molecular Photoacoustic Imaging. (2025)

Ananthakrishnan Soundaram JeevarathinamClaire E. JonesCayla ZandbergenYunfei WenAnil SoodKonstantin V. SokolovRichard R. Bouchard

molecular photoacoustic imagingnanoparticle researchphotomedicinebiophotonicsbiomolecular engineeringinhibitory activityencapsulated indocyaninemolecular biologymolecular imaging

1
2
3
4
5
133
10 / page

Anil Sood

The University of Texas MD Anderson Cancer Center

Affiliations

Center For Rna Interference And Non-Coding Rna

Department Of Gynecologic Oncology And Reproductive Medicine

Department Of Gynecologic Research

The University of Texas MD Anderson Cancer Center

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Anil Sood

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract A045: Overcoming Platelet-Mediated Immune Suppression in Ovarian Cancer. Cancer Immunology Research (2026)

immunologyabstract a045blood plateletgynecologic oncologycancer immunotherapycellular therapygynecologic cancersthrombopoiesisgynecologyovarian cancerimmunotherapy

cancer geneticscancer careradiation oncologygynecologic oncologysurvival outcomesgynecologic cancersoncologyfrontline therapycancer treatmentgynecologyovarian canceradvanced-stage ovarian cancer

Platelets Induce Vista Expression and Modulate the Ovarian Tumor Microenvironment. Platelets (2026)

blood platelethematologythrombosistumor microenvironmentovarian cancerhemostasiscell biology

Rethinking Depression Diagnosis in Ovarian Cancer: The Role of Somatic Symptoms. Cancer (2026)

cancer caremood symptomsymptom managementpsychopathologygynecologic oncologydepressionpsychiatryoncologygynecologyovarian cancer

Abstract 6520: Intratumoral Microbiome Profiling Using High-Depth Whole-Genome Sequencing Highlighted Cutibacterium Acnes in Chemoresistance in Ovarian Cancer. Cancer Research (2025)

Abstract 6795: Cystine Deprivation Overcomes Protective Effects of Hypoxia on Ferroptosis in High-Grade Serous Ovarian Cancer. Cancer Research (2025)

oxidative stressredox signalingfree radical biologyredox biologygynecologic oncologyreactive oxygen speciesoncologyhypoxia (medicine)gynecologyovarian cancer

Abstract 7153: Subclonal Mutation Load Predicts Survival and Response to Immunotherapy in Cancers With Low to Moderate Tmb. Cancer Research (2025)

immunologyabstract 7153cancer geneticsimmune checkpoint inhibitorssubclonal mutation loadcancer immunotherapyoncologyoncogenescancer cellspathologyimmunotherapy

Abstract P2-06-04: Potential Impact of the Cancer-Associated Fibroblast Secretome in the Tumor Microenvironment. Clinical Cancer Research (2025)

potential impactcancer-associated fibroblast secretomecancer researchmolecular cancercancer cellstumor microenvironmentcancer biologypathologytumor biologybiological microenvironmentscell biology

Antibody-Targeted, Liposomes Encapsulated Indocyanine Green Dye J-Aggregates as Contrast Agents for Molecular Photoacoustic Imaging. (2025)

Ananthakrishnan Soundaram JeevarathinamClaire E. JonesCayla ZandbergenYunfei WenAnil SoodKonstantin V. SokolovRichard R. Bouchard

molecular photoacoustic imagingnanoparticle researchphotomedicinebiophotonicsbiomolecular engineeringinhibitory activityencapsulated indocyaninemolecular biologymolecular imaging

1
2
3
4
5
133
10 / page